Showing results (201-210 of 872) with videos related to
Sort By:
Pageof 88
Nature Protocols|August 19, 2007
An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progressionClemens Neufert, Christoph Becker, Markus F NeurathCurrent Opinion in Gastroenterology|October 1, 2019
Anti-trafficking agents in the treatment of inflammatory bowel diseaseSebastian Zundler, Maximilian Wiendl, Markus F NeurathFrontiers in Immunology|November 11, 2017
Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory DisordersManuel Wiesinger, Diane Stoica, Susanne Roessner, et al.Scientific Reports|February 28, 2020
Intestinal ex vivo organoid culture reveals altered programmed crypt stem cells in patients with celiac diseaseWalburga Dieterich, Markus F Neurath, Yurdagül ZopfCancers|November 13, 2021
Autophagy in Cancer Therapy-Molecular Mechanisms and Current Clinical AdvancesIngo Ganzleben, Markus F Neurath, Christoph BeckerInflammatory Bowel Diseases|March 8, 2011
Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel diseaseGheorghe Hundorfean, Markus F Neurath, Jonas MudterNature Reviews. Immunology|December 18, 2007
How microorganisms tip the balance between interleukin-12 family membersStanislas Goriely, Markus F Neurath, Michel GoldmanInternational Journal of Molecular Sciences|April 19, 2019
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related DiseasesBarbara Ruder, Raja Atreya, Christoph BeckerJournal of Cellular and Molecular Medicine|November 3, 2009
Autoimmunity against type VII collagen in inflammatory bowel diseaseGheorghe Hundorfean, Markus F Neurath, Cassian SitaruCurrent Drug Targets. Inflammation and Allergy|October 27, 2005
Mucosal immunoregulation: transcription factors as possible therapeutic targetsAysefa Doganci, Markus F Neurath, Susetta FinottoPageof 88